Read business card:
(
*
Indicates a mandatory field)
Which biomarkers do you currently run for your NSCLC samples? (check all that apply)
*
PDL1
EGFR
ALK
ROS1
BRAF
KRAS
RET
MET
ERBB2
Other
How are the NSCLC biomarkers tested? (check all that apply)
*
Next-generation sequencing (NGS)
Single gene/analyte
Multiplex panel, but not NGS
Other
Where is the biomarker testing performed?
*
In-house pathology lab
Sent out
If sent out, please select the lab:
Foundation Medicine
Caris
LabCorp
Quest
NeoGenomics
Cancer Genetics, Inc.
Other
If you are not running NGS in-house, does your institution plan to adopt an NGS solution in the next 2 years?
Yes
No
Not sure
First name
*
Last name
*
Email
*
Institution
*
City
*
Country/Region
*
Please select
Canada
United States
Notes
(
255
characters remaining)
Submit